Estrogen and Related Receptors
Estrogen controls many cellular processes including growth, differentiation and function of the reproductive system. Estrogen is also responsible for the growth and maintenance of the skeleton and the normal function of the cardiovascular and nervous systems.
Estrogen and Related Receptor Agonists |
|
---|---|
Cat. No. | Product Name / Activity |
5053 | AC 186 |
Potent and selective ERβ agonist; neuroprotective | |
1494 | DPN |
Highly potent ERβ agonist | |
2266 | DY131 |
Agonist selective for estrogen-related receptors ERRβ and ERRγ | |
4276 | ERB 041 |
Potent ERβ agonist | |
2823 | α-Estradiol |
Endogenous estrogen receptor agonist | |
2824 | β-Estradiol |
Endogenous ER agonist | |
3075 | GSK 4716 |
Selective ERRγ and ERRβ agonist | |
3907 | 27-Hydroxycholesterol |
ER partial agonist; also LXR agonist | |
1426 | PPT |
Subtype-selective ERα agonist | |
8112 | SLU-PP-332 |
Potent pan-ERR agonist | |
7690 | T 112 |
Estrogen-related receptor γ agonist; promotes maturation of hiPSC-derived cardiomyocytes | |
Estrogen and Related Receptor Inverse Agonists |
|
Cat. No. | Product Name / Activity |
3928 | XCT 790 |
Selective ERRα inverse agonist | |
Estrogen and Related Receptor Antagonists |
|
Cat. No. | Product Name / Activity |
1047 | ICI 182,780 |
Estrogen receptor antagonist | |
1991 | MPP dihydrochloride |
Highly selective ERα antagonist | |
2662 | PHTPP |
Selective ERβ antagonist | |
Estrogen and Related Receptor Modulators |
|
Cat. No. | Product Name / Activity |
3412 | (Z)-4-Hydroxytamoxifen |
Metabolite of tamoxifen (Cat. No. 0999) | |
2280 | Raloxifene hydrochloride |
Selective estrogen receptor modulator (SERM) | |
6342 | Tamoxifen |
Estrogen receptor partial agonist/antagonist | |
0999 | Tamoxifen citrate |
Estrogen receptor partial agonist/antagonist | |
2676 | Y 134 |
Selective estrogen receptor modulator (SERM), selective for ERα | |
Estrogen and Related Receptor Inhibitors |
|
Cat. No. | Product Name / Activity |
4382 | Letrozole |
Potent, reversible non-steroidal aromatase inhibitor | |
Ligands |
|
Cat. No. | Product Name / Activity |
7945 | Cholesterol |
Endogenous ligand for estrogen-related receptor α (ERRα) | |
Degraders |
|
Cat. No. | Product Name / Activity |
7120 | SNIPER(ER)-87 |
Potent and selective ERα Degrader (SNIPER) | |
Other |
|
Cat. No. | Product Name / Activity |
3705 | Endoxifen |
Potent antiestrogen; ERα ligand | |
1110 | Genistein |
Estrogen receptor ligand. Also tyrosine kinase inhibitor | |
1990 | (R,R)-THC |
Potent subtype-selective ligand; ERα agonist/ERβ antagonist |
Estrogen controls many cellular processes including growth, differentiation and function of the reproductive system. In females, estrogen's main targets are the ovaries, uterus, vagina and mammary glands. In the male, target organs are the testes, prostate and epididymis. Estrogen is also responsible for the growth and maintenance of the skeleton and the normal functioning of the cardiovascular and nervous systems.
Estrogen exerts most of its actions via estrogen receptors (ER). Estrogen receptors are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily.
Today, two estrogen receptors are known, ERα and ERβ. ERα protein is highly homologous to ERβ protein, especially in the DNA and ligand binding domains, although divergence exists in the N-terminal transactivation domain. Both receptors interact with the same DNA response element and show a similar ligand binding profile. Upon ligand binding estrogen receptors undergo a conformational change allowing spontaneous dimerization to form either homo- or heterodimers. As a dimer, the estrogen receptor binds to the estrogen response element (ERE) in the promoter region of target genes. ERα and ERβ are present in a broad spectrum of tissues.
Three estrogen-related receptors (ERRs) - ERRα, ERRβ and ERRγ - have also been identified. Classified as 'orphan' nuclear receptors, they do not bind endogenous estrogens; instead, they are activated by co-regulatory proteins and bind the ERE and ERR response elements (ERREs) as homodimers, exerting transcriptional control of energy homeostasis. As a result, they may be useful therapeutic targets for metabolic diseases, such as obesity and diabetes, as well as cancer.
External sources of pharmacological information for Estrogen and Related Receptors :
Pathways for Estrogen and Related Receptors
Estrogen Signaling Pathway
Estrogen is a steroid hormone that is responsible for the regulation of growth, differentiation and function of the reproductive system. Estrogen signaling is often dysregulated in breast cancer and osteoporosis.Estrogen Receptor Gene Data
Gene | Species | Gene Symbol | Gene Accession No. | Protein Accession No. |
---|---|---|---|---|
ERα | Human | ESR1 | NM_001122742 | P03372 |
Mouse | Esr1 | NM_007956 | P19785 | |
Rat | Esr1 | NM_012689 | P06211 | |
ERβ | Human | ESR2 | NM_001040275 | Q92731 |
Mouse | Esr2 | NM_207707 | O08537 | |
Rat | Esr2 | NM_012754 | Q62986 | |
ESRRα | Human | ESRRA | NM_004451 | X51416 |
Mouse | Esrra | NM_007953 | O08580 | |
Rat | Esrra | NM_001008511 | Q5QJV7 | |
ESRRβ | Human | ESRRB | NM_004452 | X51417 |
Mouse | Esrrb | NM_011934 | Q61539 | |
Rat | Esrrb | NM_001008516 | P11475 | |
ESRRγ | Human | ESRRG | NM_206595 | AF058291 |
Mouse | Esrrg | NM_011935 | P62509 | |
Rat | Esrrg | NM_203336 | P62510 |